Clinical Trial

An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Enrolling by Invitation Phase 2
View on ClinicalTrials.gov →
Summary
Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2029-01 -> 2026-11 2026-07-31
minor Completion moved earlier: 2029-01 -> 2026-11 2026-07-31
Trial Details
NCT Number NCT06169397
Lead Sponsor Xentria, Inc.
Conditions Pulmonary Sarcoidosis
Enrollment 94 participants
Start Date 2024-03-01
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-30